CLEVELAND, March 10, 2021 /PRNewswire/ -- MIM Software Inc., a leading global provider of medical imaging software, announced today it has received CE Mark approval for its deep learning auto-contouring software, Contour ProtégéAI.
Contour ProtégéAI is a practical auto-contouring solution that uses deep learning algorithms to generate accurate initial results with minimal editing required. The software provides next-generation segmentation and makes contouring quicker and more efficient without sacrificing accuracy.
User feedback and a determination to continuously improve auto-segmentation were key drivers in developing the product.
"We recognize that our customers are constantly looking to improve their clinical workflow efficiency while maintaining high-quality patient care," said Andrew Nelson, Chief Executive Officer of MIM Software Inc. "We are excited to extend our Contour ProtégéAI product to a wider audience to further reduce the burden of contouring on a global scale."
Contour ProtégéAI received FDA 510(k) clearance in the United States in July 2020.
About MIM Software Inc.
MIM Software is committed to enhancing patient care by providing customer-focused and innovative imaging, workflow, and data solutions. MIM Software offers a central software package that allows industry-leading oncology tools to be utilized together to ensure plan quality and maximize effective data usage and efficiency.
Headquartered in Cleveland, OH, MIM Software is a global and privately held company with offices worldwide.
To learn more about MIM Software, visit www.mimsoftware.com.
Logo - https://mma.prnewswire.com/media/709760/MIM_Software_Logo.jpg
